PIK3CA and cervical cancer: The combination would be a rational therapy to be investigated in cervical cancers with DDR defects derived from the presence of viral oncogenes and mutations of genes encoding for DDR proteins, which as shown here are present in a significant minority of squamous cervical carcinomas, mostly with PIK3CA mutations.